000 01118 a2200277 4500
005 20250512022512.0
264 0 _c19890309
008 198903s 0 0 eng d
022 _a0022-2828
024 7 _a10.1016/s0022-2828(88)80083-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRhodes, D G
245 0 0 _aDiscussion of "Why do some drugs preferentially block open sodium channels?": consideration of other significant factors in the binding process.
_h[electronic resource]
260 _bJournal of molecular and cellular cardiology
_cJun 1988
300 _a571-2 p.
_bdigital
500 _aPublication Type: Editorial; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Arrhythmia Agents
_xpharmacology
650 0 4 _aCell Membrane
_xphysiology
650 0 4 _aHeart
_xphysiology
650 0 4 _aHumans
650 0 4 _aMyocardium
_xcytology
650 0 4 _aSodium Channels
_xdrug effects
700 1 _aHerbette, L G
773 0 _tJournal of molecular and cellular cardiology
_gvol. 20
_gno. 6
_gp. 571-2
856 4 0 _uhttps://doi.org/10.1016/s0022-2828(88)80083-x
_zAvailable from publisher's website
999 _c2856919
_d2856919